IP Verse

Anti-Pvrig Antibodies And Methods Of Use - EP3653221

The patent EP3653221 was granted to Compugen on Aug 3, 2022. The application was originally filed on Feb 19, 2016 under application number EP19214231A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3653221

COMPUGEN
Application Number
EP19214231A
Filing Date
Feb 19, 2016
Status
Granted And Under Opposition
Jul 1, 2022
Grant Date
Aug 3, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GLAXOSMITHKLINEMay 2, 2023LEFEVREADMISSIBLE
ZACCO DENMARKMay 2, 2023-ADMISSIBLE

Patent Citations (46) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS19990315584-
DESCRIPTIONUS20080462008-
DESCRIPTIONEP0154316
DESCRIPTIONEP0401384
DESCRIPTIONEP1176195
DESCRIPTIONUS2004110704
DESCRIPTIONUS3773919
DESCRIPTIONUS4485045
DESCRIPTIONUS4544545
DESCRIPTIONUS5013556
DESCRIPTIONUS5057313
DESCRIPTIONUS5624821
DESCRIPTIONUS5648260
DESCRIPTIONUS5677425
DESCRIPTIONUS5811097
DESCRIPTIONUS5837243
DESCRIPTIONUS5869046
DESCRIPTIONUS5922845
DESCRIPTIONUS6121022
DESCRIPTIONUS6165745
DESCRIPTIONUS6194551
DESCRIPTIONUS6277375
DESCRIPTIONUS6331175
DESCRIPTIONUS6737056
DESCRIPTIONUS7371826
DESCRIPTIONUS8883973
DESCRIPTIONWO0029004
DESCRIPTIONWO0042072
DESCRIPTIONWO03035835
DESCRIPTIONWO2004091658
DESCRIPTIONWO2009126688
DESCRIPTIONWO9413804
DESCRIPTIONWO9429351
DESCRIPTIONWO9738731
DESCRIPTIONWO9954342
OPPOSITIONEP2067791
OPPOSITIONWO2004058805
OPPOSITIONWO2012178128
OPPOSITIONWO2013184912
OPPOSITIONWO2017021526
OPPOSITIONWO2017041004
SEARCHEP2067791
SEARCHWO2004058805
SEARCHWO2012178128
SEARCHWO2017021526
SEARCHWO2017041004

Non-Patent Literature (NPL) Citations (120) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- AALBERSE, RCSCHUURMAN J., Immunology, (20020000), vol. 105, pages 9 - 19-
DESCRIPTION- ALTSCHUL et al., JMol. Biol., (19900000), vol. 215, pages 403 - 10-
DESCRIPTION- ALTSCHUL et al., Nucleic Acids Res., (19970000), vol. 25, no. 17, pages 3389 - 3402-
DESCRIPTION- BARBER et al., Nature, (20060000), vol. 439, pages 682 - 7-
DESCRIPTION- BECERK et al., Mutat. Res, (20110617), vol. 722, no. 2, pages 171 - 182-
DESCRIPTION- BHADRA et al., Proc Natl. Acad Sci., (20110000), vol. 108, no. 22, pages 9196 - 201-
DESCRIPTION- Bioinformatics, (20100000), vol. 26, no. 4, pages 493 - 500-
DESCRIPTION- BIRD et al., Science, (19880000), vol. 242, pages 423 - 426-
DESCRIPTION- BRAHMAMDAM et al., J. Leukoc. Biol., (20100000), vol. 88, pages 233 - 240-
DESCRIPTION- BYRNE WL. et al., Cancer Res., (20110000), vol. 71, page 691520-
DESCRIPTION- CAMPO et al., Nod. Pathol., (20130100), vol. 26, no. 1, pages S97 - S 110-
DESCRIPTION- CHAN CACARTER PJ, Nature Rev Immunol, (20100000), vol. 10, pages 301 - 316-
DESCRIPTION- CHANG et al., Critical Care, (20130000), vol. 17, page R85-
DESCRIPTION- CHOTHIALESK, J. Mol. Biol., (19870000), vol. 196, pages 901 - 917-
DESCRIPTION- CINELOPAL, Crit. Care Med., (20090000), vol. 37, pages 291 - 304-
DESCRIPTION- Clin Immunol., (20110800), vol. 140, no. 2, pages 167 - 76-
DESCRIPTION- CRAWFORD et al., Curr Opin Immunol, (20090000), vol. 21, pages 179 - 186-
DESCRIPTION- CRAWFORD et al., Curr Opin Immunol., (20090000), vol. 21, pages 179 - 186-
DESCRIPTION- DRAKEKLAKAMP, Journal of Immunol Methods, (20070000), vol. 318, pages 147 - 152-
DESCRIPTION- DRANOFF et al., Proc. Natl. Acad. Sci U.S.A., (19930000), vol. 90, pages 3539 - 43-
DESCRIPTION- E. MEYERSW. MILLER, Comput. Appl. Biosci., (19880000), vol. 4, pages 11 - 17-
DESCRIPTION- EPSTEIN et al., Proc Natl Acad Sci USA, (19850000), vol. 82, page 3688-
DESCRIPTION- FACCIABENE A. et al., Cancer Res, (20120000), vol. 72, no. 9, pages 2162 - 71-
DESCRIPTION- GABIZON et al., J National Cancer Inst, (19890000), vol. 81, page 1484-
DESCRIPTION- GABRILOVICH DI.NAGARAJ S, Nature Reviews, (20090000), vol. 9, pages 162 - 174-
DESCRIPTION- GALLUZZI et al., Nature Reviews - Drug discovery, (20120000), vol. 11, pages 215 - 233-
DESCRIPTION- GOLDEN-MASON et al., J Virol., (20090000), vol. 83, pages 9122 - 30-
DESCRIPTION- GOODKIND et al., Computers and Chem. Eng., (20050000), vol. 29, no. 3, page 589-
DESCRIPTION- GOYERTSILVER, J Leuk. Biol., (20100000), vol. 88, no. 2, pages 225 - 226-
DESCRIPTION- GREENBERG, R.RIDDELL, S., Science, (19990000), vol. 285, pages 546 - 51-
DESCRIPTION- GUNTUPALLI et al., Crit Care Med., (20130000), vol. 41, no. 3, pages 706 - 716-
DESCRIPTION- HAHNE, M. et al., Science, (19960000), vol. 274, pages 1363 - 1365-
DESCRIPTION- HAN et al., Bioinform. Biol., vol. 9, no. 1, pages 29 - 46-
DESCRIPTION- HAWKINS et al., J. Mol. Biol., (19920000), vol. 226, pages 889 - 896-
DESCRIPTION- HE et al., J. Immunol., (20040000), vol. 173, pages 4919 - 28-
DESCRIPTION- HOFMEYER et al., JBiomedBiotechnol, vol. 2011-
DESCRIPTION- HOFMEYER et al., JBiomedBiotechnol., vol. 2011-
DESCRIPTION- HOLLIGER et al., Proc. Natl. Acad. Sci. U.S.A., (19930000), vol. 90, pages 6444 - 6448-
DESCRIPTION- HOTCHKISS et al., Lancet Infect. Dis., (20130000), vol. 13, pages 260 - 268-
DESCRIPTION- HOWARD, M.O'GARRA, A., Immunology Today, (19920000), vol. 13, pages 198 - 200-
DESCRIPTION- HUANG et al., PNAS, (20090000), vol. 106, pages 6303 - 6308-
DESCRIPTION- HUSTON et al., Proc. Natl. Acad. Sci. U.S.A., (19880000), vol. 85, pages 5879 - 5883-
DESCRIPTION- HUSTON et al., Proc. Natl. Acad. Sci. USA, (19880000), vol. 85, pages 5879 - 5883-
DESCRIPTION- HUSTON, Surg. Infect., (20120000), vol. 13, pages 187 - 193-
DESCRIPTION- HUTLOFF, A. et al., Nature, (19990000), vol. 397, pages 262 - 266-
DESCRIPTION- HWANG et al., Proc Natl Acad Sci USA, (19800000), vol. 77, page 4030-
DESCRIPTION- INOUE et al., Shock, (20110000), vol. 36, pages 38 - 44-
DESCRIPTION- ITO, N. et al., Immunobiology, (20000000), vol. 201, no. 5, pages 527 - 40-
DESCRIPTION- JACKSON et al., J. Immunol., (19950000), vol. 154, no. 7, pages 3310 - 2004-
DESCRIPTION- JEFFERIS et al., Immunol Lett, (20020000), vol. 82, pages 57 - 65-
DESCRIPTION- KAUFMANN et al., J Immunol, (20090000), vol. 182, pages 5891 - 5897-
DESCRIPTION- KEHRL, J. et al., J. Exp. Med., (19860000), vol. 163, pages 1037 - 1050-
DESCRIPTION- KIM, N et al., Science, (19940000), vol. 266, pages 2011 - 2013-
DESCRIPTION- KUGLER, A. et al., Nature Medicine, (20000000), vol. 6, pages 332 - 336-
DESCRIPTION- LEENTJENS et al., Am J Respir Crit Care Med, (20120000), vol. 186, pages 838 - 845-
DESCRIPTION- MARKS et al., Biotechnology, (19920000), vol. 10, pages 779 - 783-
DESCRIPTION- MATSUDA et al., J Nippon Med Sch., (20120000), vol. 79, pages 4 - 18-
DESCRIPTION- MCCAFFERTY et al., Nature, (19900000), vol. 348, pages 552 - 554-
DESCRIPTION- MELERO, I. et al., Nature Medicine, (19970000), vol. 3, pages 682 - 685-
DESCRIPTION- MELLMAN I. et al., Nature, (20110000), vol. 480, pages 22 - 29-
DESCRIPTION- MORGAN et al., Science, (20060000), vol. 314, pages 126 - 129-
DESCRIPTION- MOUKTAROUDI et al., Crit Care, (20100000), vol. 14, page 17-
DESCRIPTION- NEEDLEMANWUNSCH, J. Mol. Biol., (19700000), vol. 48, pages 444 - 453-
DESCRIPTION- NEIGHBORS et al., JImmunother, (20080000), vol. 31, no. 7, pages 644 - 55-
DESCRIPTION- NESTLE, F. et al., Nature Medicine, (19980000), vol. 4, pages 328 - 332-
DESCRIPTION- NOA STANIETSKY, journal of immunology, vol. 106, no. 42, pages 17858 - 17863-
DESCRIPTION- PALUCKABANCHEREAU, Nat. Rev. Cancer, vol. 12, no. 4, pages 265 - 277-
DESCRIPTION- PARDOLL, J Exp Med., (20120000), vol. 209, no. 2, pages 201 - 209-
DESCRIPTION- PAYEN et al., Crit Care, (20130000), vol. 17, page 118-
DESCRIPTION- RESTIFO et al., Cancer Immunol. Immunother., (20130000), vol. 62, no. 4, pages 727 - 36-
DESCRIPTION- RESTIFO, N.SZNOL, M., Cancer Vaccines, Ch., vol. 61, pages 3023 - 3043-
DESCRIPTION- RIDGE, J. et al., Nature, (19980000), vol. 393, pages 474 - 478-
DESCRIPTION- RIVAS et al., J Immunol., (20090000), vol. 183, pages 4284 - 91-
DESCRIPTION- ROBERT J JOHNSTON, Cancer cell, (20141208), vol. 26, no. 6, pages 923 - 937-
DESCRIPTION- ROSENBERG, S A, Immunity, (19990000), vol. 10, pages 281 - 7-
DESCRIPTION- SCHLOM J, J Natl Cancer Inst, (20120000), vol. 104, pages 599 - 613-
DESCRIPTION- SHARPE et al., Nat Immunol, (20070000), vol. 8, pages 239 - 245-
DESCRIPTION- SHIELDS, R. L. et al., J. Biol. Chem., (20010000), vol. 276, pages 6591 - 6604-
DESCRIPTION- SHIELDS, R. L. et al., J. Biol. Chem., (20020000), vol. 277, pages 26733 - 26740-
DESCRIPTION- SHIER et al., Gene, (19950000), vol. 169, pages 147 - 155-
DESCRIPTION- SHI et al., Nature, (20130000), vol. 493, pages 111 - 115-
DESCRIPTION- SICA, G L et al., Immunity, (20030000), vol. 18, pages 849 - 61-
DESCRIPTION- SUOT, RSRIVASTAVA, P, Science, (19950000), vol. 269, pages 1585 - 1588-
DESCRIPTION- TAMURA, Y. et al., Science, (19970000), vol. 278, pages 117 - 120-
DESCRIPTION- TARENTINO, A. L. et al., Biochem., (19750000), vol. 14, pages 5516 - 23-
DESCRIPTION- TAYLOR et al., BioMed Res., vol. 2014, page 8-
DESCRIPTION- TOMLINSON, Methods Enzymol., (20000000), vol. 326, pages 461 - 479-
DESCRIPTION- TRAPNELL et al., Nat Biotechnol., (20100500), vol. 28, no. 5, pages 511 - 5-
DESCRIPTION- UMANA et al., Nat. Biotech., (19990000), vol. 17, pages 176 - 180-
DESCRIPTION- UNSINGER et al., J. Immunol., (20100000), vol. 184, pages 1401 - 1409-
DESCRIPTION- VALU et al., Nature, (20090000), vol. 458, pages 206 - 210-
DESCRIPTION- WANG et al., "Recent Advances in Capillary Electrophoresis-Based Proteomic Techniques for Biomarker Discovery", Methods. Mol. Biol., (20130000), vol. 984, pages 1 - 12-
DESCRIPTION- WANNEMUEHLER et al., J. Surg. Res., (20120000), vol. 173, pages 113 - 26-
DESCRIPTION- WATANABE, N. et al., Nat Immunol, (20030000), vol. 4, pages 670 - 9-
DESCRIPTION- WATTS, "TNF/TNFR Family Members in Co-stimulation of T Cell Responses", Ann. Rev. Immunol., (20050000), vol. 23, pages 23 - 68-
DESCRIPTION- WEINBERG, A. et al., Immunol, (20000000), vol. 164, pages 2160 - 2169-
DESCRIPTION- WITTEBOLE et al., Mediators of Inflammation, (20100000), vol. 10-
DESCRIPTION- YAMANE-OHNUKI et al., Biotechnol Bioeng, (20040000), vol. 87, pages 614 - 22-
DESCRIPTION- YE et al., Nucleic Acids Res., (20130000), vol. 41, pages W34 - W40-
DESCRIPTION- ZHANG et al., Crit. Care, (20110000), vol. 15, page R70-
DESCRIPTION- ZHANG et al., Critical Care, (20100000), vol. 14, page R220-
DESCRIPTION- DELLINGER et al., "International Guidelines for Management of Severe Sepsis and Septic Shock", Intensive Care Med, (20130000), vol. 39, doi:10.1007/s00134-012-2769-8, pages 165 - 228, XP055286924
DESCRIPTION- WANG, "Immune Suppression by Tumor Specific CD4+ Regulatory T cells in Cancer", Semin. Cancer. Biol., (20060000), vol. 16, doi:10.1016/j.semcancer.2005.07.009, pages 73 - 79, XP024908039
DESCRIPTION- GREENWALD et al., "The B7 Family Revisited", Ann. Rev. Immunol., (20050000), vol. 23, doi:10.1146/annurev.immunol.23.021704.115611, pages 515 - 48, XP002481408
DESCRIPTION- SADUM et al., "Immune Signatures of Murine and Human Cancers Reveal Unique Mechanisms of Tumor Escape and New Targets for Cancer Immunotherapy", Clin. Cane. Res., (20070000), vol. 13, no. 13, doi:10.1158/1078-0432.CCR-07-0016, pages 4016 - 4025, XP055248327
EXAMINATION- WINKLER K ET AL, "Changing the antigen binding specificity by single point mutations of an anti-p24 (HIV-1) antibody", THE JOURNAL OF IMMUNOLOGY, WILLIAMS & WILKINS CO, US, (20001015), vol. 165, no. 8, ISSN 0022-1767, pages 4505 - 4514, XP002579393-
EXAMINATION- RUDIKOFF S ET AL, "Single amino acid substitution altering antigen-binding specificity", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, (19820301), vol. 79, doi:10.1073/PNAS.79.6.1979, ISSN 0027-8424, pages 1979 - 1983, XP007901436
EXAMINATION- IBA Y ET AL, "CHANGES IN THE SPECIFICITY OF ANTIBODIES AGAINST STEROID ANTIGENS BY INTRODUCTION OF MUTATIONS INTO COMPLEMENTARITY-DETERMINING REGIONS OF THE VH DOMAIN", PROTEIN ENGINEERING, OXFORD UNIVERSITY PRESS, SURREY, GB, (19980101), vol. 11, no. 5, doi:10.1093/PROTEIN/11.5.361, ISSN 0269-2139, pages 361 - 370, XP002953909
OPPOSITION- Anonymous, "Instructions for Authors", JEM, The Wayback Machine, (20151210), pages 1 - 2, JEM, URL: http://web.archive.Org/web/20160110120437/http://jem.rupress.org:80/site, (20230511), XP093046055-
OPPOSITION- "PVRIG antibody -middle region Rabbit Polyclonal Antibody Catalog# Al13083 Specification PVRIG antibody -middle region -Product Information Application WB Primary Accession Q6 DK 17 Other Accession NM_024070, NP 076975 Reactivity Human Predicted Human Host Rabbit Clonality Polyclonal Calculated MW 34k", Physiol. Genomics, (20060101), pages 201 - 218-
OPPOSITION- Johnston Robert J.; Comps-Agrar Laetitia; Hackney Jason; Yu Xin; Huseni Mahrukh; Yang Yagai; Park Summer; Javinal Vincent; Chiu Henry; Irving Bryan; Eaton Dan L.; Grogan Jane L. , "The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8+T Cell Effector Function", CANCER CELL, US , (20141126), vol. 26, no. 6, doi:10.1016/j.ccell.2014.10.018, ISSN 1535-6108, pages 923 - 937, XP029111576
OPPOSITION- XIN YU et al., "The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells", NATURE IMMUNOLOGY, (20090101), vol. 10, no. 1, doi:10.1038/ni.1674, pages 48 - 57, XP055273979
OPPOSITION- N. STANIETSKY et al., "The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (20091020), vol. 106, no. 42, doi:10.1073/pnas.0903474106, pages 17858 - 17863, XP055215810
OPPOSITION- Yuwen Zhu et al, "Identification of CD112R as a novel checkpoint for human T cells", Journal of Experimental Medicine, US , (20160208), vol. 213, no. 2, doi:10.1084/jem.20150785, ISSN 0022-1007, pages 167 - 176, XP055314642
OPPOSITION- ROTMAN et al., "Identification of novel immune checkpoints as targets for cancer immunotherapy", Journal for ImmunoTherapy of Cancer, (20130000), vol. 1, doi:10.1186/2051-1426-1-S1-P135, page P135, XP021167082
SEARCH- Gene Id, "PVRIG antibody -middle region Rabbit Polyclonal Antibody Catalog # AI13083 Specification PVRIG antibody -middle region -Product Information Application WB Primary Accession Q6DKI7 Other Accession NM_024070, NP_076975 Reactivity Human Predicted Human Host Rabbit Clonality Polyclonal Calculated MW 34k", Physiol. Genomics, (20060101), pages 201 - 218, URL: http://www.funakoshi.co.jp/data/datasheet/ABG/AI13083.pdf, XP055273924 [X] 6 * the whole document * [I] 1-5,7-14-
SEARCH- ZHU YUWEN ET AL, "Identification of CD112R as a novel checkpoint for human T cells", JOURNAL OF EXPERIMENTAL MEDICINE, ROCKEFELLER UNIV. PRESS, NEW YORK, NY, USA, (20160208), vol. 213, no. 2, ISSN 1540-9538, pages 167 - 176, XP009190107 [PX] 6 * figures 1-5 *-
SEARCH- XIN YU ET AL, "The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells", NATURE IMMUNOLOGY, GB, (20090101), vol. 10, no. 1, doi:10.1038/ni.1674, ISSN 1529-2908, pages 48 - 57, XP055273979 [A] 1-14 * figures 1-8 *
SEARCH- N. STANIETSKY ET AL, "The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (20091020), vol. 106, no. 42, doi:10.1073/pnas.0903474106, ISSN 0027-8424, pages 17858 - 17863, XP055215810 [A] 1-14 * figures 1-6 *
SEARCH- GALIT ROTMAN ET AL, "Identification of novel immune checkpoints as targets for cancer immunotherapy", JOURNAL FOR IMMUNOTHERAPY OF CANCER, BIOMED CENTRAL LTD, LONDON, UK, (20131107), vol. 1, no. Suppl 1, doi:10.1186/2051-1426-1-S1-P135, ISSN 2051-1426, page P135, XP021167082 [A] 1-14 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents